Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Comput Biol Med ; 167: 107621, 2023 12.
Article in English | MEDLINE | ID: mdl-37907030

ABSTRACT

Drug-target affinity (DTA) prediction as an emerging and effective method is widely applied to explore the strength of drug-target interactions in drug development research. By predicting these interactions, researchers can assess the potential efficacy and safety of candidate drugs at an early stage, narrowing down the search space for therapeutic targets and accelerating the discovery and development of new drugs. However, existing DTA prediction models mainly use graphical representations of drug molecules, which lack information on interactions between individual substructures, thus affecting prediction accuracy and model interpretability. Therefore, transformer and diffusion on drug graphs in DTA prediction (TDGraphDTA) are introduced to predict drug-target interactions using multi-scale information interaction and graph optimization. An interactive module is integrated into feature extraction of drug and target features at different granularity levels. A diffusion model-based graph optimization module is proposed to improve the representation of molecular graph structures and enhance the interpretability of graph representations while obtaining optimal feature representations. In addition, TDGraphDTA improves the accuracy and reliability of predictions by capturing relationships and contextual information between molecular substructures. The performance of the proposed TDGraphDTA in DTA prediction was verified on three publicly available benchmark datasets (Davis, Metz, and KIBA). Compared with state-of-the-art baseline models, it achieved better results in terms of consistency index, R-squared, etc. Furthermore, compared with some existing methods, the proposed TDGraphDTA is demonstrated to have better structure capturing capabilities by visualizing the feature capturing capabilities of the model using Grad-AAM toxicity labels in the ToxCast dataset. The corresponding source codes are available at https://github.com/Lamouryz/TDGraph.


Subject(s)
Benchmarking , Drug Development , Reproducibility of Results , Diffusion , Software
2.
J Imaging ; 7(1)2021 Jan 07.
Article in English | MEDLINE | ID: mdl-34460577

ABSTRACT

Person re-identification (Re-ID) is challenging due to host of factors: the variety of human positions, difficulties in aligning bounding boxes, and complex backgrounds, among other factors. This paper proposes a new framework called EXAM (EXtreme And Moderate feature embeddings) for Re-ID tasks. This is done using discriminative feature learning, requiring attention-based guidance during training. Here "Extreme" refers to salient human features and "Moderate" refers to common human features. In this framework, these types of embeddings are calculated by global max-pooling and average-pooling operations respectively; and then, jointly supervised by multiple triplet and cross-entropy loss functions. The processes of deducing attention from learned embeddings and discriminative feature learning are incorporated, and benefit from each other in this end-to-end framework. From the comparative experiments and ablation studies, it is shown that the proposed EXAM is effective, and its learned feature representation reaches state-of-the-art performance.

SELECTION OF CITATIONS
SEARCH DETAIL
...